Ferring Pharmaceuticals Inc. et al v. Serenity Pharmaceuticals, LLC et al

  1. July 06, 2020

    Ferring And Serenity's SDNY Patent Trial Kicks Off Over Zoom

    The Zoom-based patent showdown between drugmakers Ferring and Serenity kicked off Monday with highly technical testimony from a pharmaceuticals expert — as well as some exasperation from Southern District of New York Chief Judge Colleen McMahon at the pace of the digital proceedings.

  2. June 26, 2020

    COVID-19 IP Catch-Up: Mask Sales & Remote Source Codes

    A Texas federal judge authorized a novel way of reviewing source code during the pandemic, mask makers are still bringing trademark suits, and patent litigation between drugmakers in New York is finally ready to go to trial. Here are some recent intellectual property updates tied to the outbreak that you may have missed.

  3. June 25, 2020

    Chief SDNY Judge Says Drug Cos. Ready For Remote IP Trial

    A top New York federal judge said Thursday that drugmakers Ferring and Serenity are ready to start a full-scale online patent trial in early July, saying that while the pioneering case will be "a little weird," it'll set an important example from a court that leads the nation in commercial litigation.

  4. June 19, 2020

    COVID-19 IP Catch-Up: Trials Get Delayed, Moved To Video

    As the COVID-19 pandemic wages on, more trials are being pushed into August and beyond, and others are gearing up for remote proceedings. Here are some recent intellectual property updates tied to the outbreak that you may have missed.

  5. June 17, 2020

    Virus Fears Mean Serenity, Ferring Will Have Remote IP Trial

    Drugmakers Ferring Pharmaceuticals Inc. and Serenity Pharmaceuticals LLC told a New York federal court on Tuesday that, due to the pandemic, they won't be appearing in person for a bench trial set for July over patents linked to anti-diuretic medicines, though Ferring wants the court to leave open the possibility of in-person closing arguments.

  6. May 22, 2020

    COVID-19 IP Catch-Up: Courts Divided On Getting IP To Trial

    Intellectual property proceedings impacted by the COVID-19 pandemic have been pressing along on different timelines throughout the country, with live oral arguments resumed for a case in Michigan, trials further delayed in California and witnesses allowed to stay home in New York. The Federal Circuit, taking the state-by-state unpredictability into account, has called off in-person arguments indefinitely. 

  7. May 20, 2020

    NY Judge Won't Require In-Person Testimony In IP Bench Trial

    A New York federal judge said Wednesday she won't require witnesses to testify in person in an upcoming July bench trial over a patent dispute between two drugmakers involving the nighttime urination medication Nocdurna, noting that many witnesses in the case are older people who are skittish about traveling.

  8. May 01, 2020

    COVID-19 IP Catch-Up: Looming Trials, Jeff Dunham's Dummy

    The copyright and patent offices have pushed back certain deadlines as the COVID-19 pandemic continues, while at least one intellectual property bench trial is about to proceed over video. Here, Law360 pulls together all the updates you might have missed, including victories for 3M in its trademark campaign and a new suit by comedian Jeff Dunham seeking to protect his image.

  9. April 28, 2020

    Ferring, Serenity Trial Delayed After Attys Cite Virus Concerns

    The Southern District of New York's chief judge on Tuesday pushed back a high-profile drug patent trial from May to July after lawyers for Ferring Pharmaceuticals Inc. and Serenity Pharmaceuticals LLC expressed concerns about the impact of the COVID-19 pandemic on the proceedings.

  10. April 27, 2020

    SDNY Chief Judge's May IP Trial Plan Has Lawyers Nervous

    Lawyers for Ferring Pharmaceuticals Inc. and Serenity Pharmaceuticals LLC told the Southern District of New York's chief judge Friday they are worried about her plan to hold a late-May bench trial in their drug patent fight, saying coronavirus curbs render "uncertain" the potential to go forward.